Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

Study Identifier
192024-024
CT.gov Identifier
NCT00651859
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Other
  • Ocular Hypertension
    • Study Drug
  • Bimatoprost 0.01% Ophthalmic Solution
  • Bimatoprost 0.03% Ophthalmic Solution
  • Bimatoprost Vehicle Ophthalmic Solution
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    20+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Ethnically Japanese patients with glaucoma or ocular hypertension in each eye who require IOP-lowering therapy in both eyes
    Exclusion Criteria:
    * Uncontrolled systemic disease * Use of bimatoprost or an ocular prostaglandin (eg, latanoprost, travoprost) within 6 weeks prior to baseline (Day 0)

    Protocol Summary

    This study evaluates the safety and efficacy of once-daily bimatoprost 0.03% and 0.01% ophthalmic solutions compared with once-daily administered bimatoprost vehicle ophthalmic solution for 2 weeks in ethnically Japanese patients with open-angle glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    San Francisco, California, United States
    Status
    Not applicable